Miami, FL, United States of America

Weijun Lu

This inventor holds 1 USPTO granted patent. Top assignee: Noven Pharmaceuticals, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weijun Lu. Retrieved from https://idiyas.com/inventor/weijun-lu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Weijun Lu: Innovator in Transdermal Drug Delivery

Introduction

Weijun Lu is a notable inventor based in Miami, FL (US). She has made significant contributions to the field of drug delivery systems, particularly through her innovative work on transdermal compositions.

Latest Patents

Weijun Lu holds a patent for "Amphetamine transdermal compositions with acrylic block copolymer." This patent describes transdermal drug delivery compositions that comprise amphetamine, methods of making them, and therapeutic methods using them. The compositions are provided in a flexible, finite form, such as patch-type systems, and include a polymer matrix that contains amphetamine and an acrylic block copolymer. She has 1 patent to her name.

Career Highlights

Weijun Lu is currently employed at Noven Pharmaceuticals, Inc., where she continues to advance her research in pharmaceutical innovations. Her work focuses on improving drug delivery methods to enhance patient outcomes.

Collaborations

Throughout her career, Weijun has collaborated with esteemed colleagues, including Robert Lambert and Jun Liao. These partnerships have contributed to her success in developing effective drug delivery systems.

Conclusion

Weijun Lu's contributions to transdermal drug delivery highlight her innovative spirit and dedication to improving healthcare solutions. Her work continues to influence the pharmaceutical industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…